Summit Financial Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
SAM
GA
PFS
AIP
ONB
VFM
QCM
ERP
BIAS
Summit Financial Wealth Advisors's NVO Position: Q2 2026 in Review
Summit Financial Wealth Advisors increased its Novo Nordisk (NVO) stake by 3.5% in Q2 2026, buying an estimated $22.9K and bringing the position to 15,600 shares worth $748K. The position accounts for 0.1% of the portfolio, ranked #98.
Summit Financial Wealth Advisors first reported a position in NVO in Q4 2015 and has held it in 24 quarters since. The position peaked at $1.41M in Q2 2024. 205 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Summit Financial Wealth Advisors held 15,600 shares of Novo Nordisk worth $748K as of Q2 2026.
- Summit Financial Wealth Advisors bought 534 Novo Nordisk shares in Q2 2026, an estimated $22.9K.
- Novo Nordisk made up 0.1% of Summit Financial Wealth Advisors's portfolio in Q2 2026, its #98 holding.
- Summit Financial Wealth Advisors first reported a position in Novo Nordisk in Q4 2015 and has held it in 24 quarters since.
- Summit Financial Wealth Advisors's Novo Nordisk position peaked at $1.41M in Q2 2024.
- 205 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Summit Financial Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.